Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Decibel Therapeutics Inc (DBTX)
Decibel Therapeutics Inc (DBTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 123,374
  • Shares Outstanding, K 25,127
  • Annual Sales, $ 0 K
  • Annual Income, $ -63,010 K
  • 60-Month Beta -0.43
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.30
Trade DBTX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.53
  • Most Recent Earnings $-0.73 on 08/11/23
  • Latest Earnings Date 11/08/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 15.71%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate -0.61
  • Number of Estimates 1
  • High Estimate -0.61
  • Low Estimate -0.61
  • Prior Year -0.64
  • Growth Rate Est. (year over year) +4.69%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.88 +0.61%
on 09/21/23
5.26 -6.65%
on 08/28/23
-0.20 (-3.91%)
since 08/22/23
3-Month
2.70 +81.85%
on 08/08/23
5.26 -6.65%
on 08/28/23
+0.91 (+22.75%)
since 06/22/23
52-Week
1.61 +204.97%
on 12/30/22
5.40 -9.07%
on 02/09/23
+1.00 (+25.58%)
since 09/22/22

Most Recent Stories

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DBTX, CPRI, CEQP, ESTE

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

DBTX : 4.91 (-0.81%)
CPRI : 45.82 (-0.67%)
CEQP : 28.26 (+4.36%)
ESTE : 21.17 (+0.47%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TRHC, VRTV, CTG, DBTX

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

TRHC : 10.50 (+0.86%)
VRTV : 169.99 (+0.02%)
CTG : 10.50 (+0.10%)
DBTX : 4.91 (-0.81%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VRTV, CTG, DBTX, CPRI

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

VRTV : 169.99 (+0.02%)
CTG : 10.50 (+0.10%)
DBTX : 4.91 (-0.81%)
CPRI : 45.82 (-0.67%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMNB, DBTX, TRHC

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AMNB : 44.59 (-1.17%)
DBTX : 4.91 (-0.81%)
TRHC : 10.50 (+0.86%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TRHC, DBTX, VRTV, ZYNE

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

TRHC : 10.50 (+0.86%)
DBTX : 4.91 (-0.81%)
VRTV : 169.99 (+0.02%)
ZYNE : 1.3000 (+2.36%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTG, DBTX, WMC, MITT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

CTG : 10.50 (+0.10%)
DBTX : 4.91 (-0.81%)
WMC : 9.18 (+4.44%)
MITT : 6.06 (-0.33%)
Shareholder Alert: Ademi LLP investigates whether Decibel Therapeutics, Inc. has obtained a Fair Price in its transaction with Regeneron

/PRNewswire/ -- Ademi LLP is investigating Decibel (NASDAQ: DBTX) for possible breaches of fiduciary duty and other violations of law in its transaction with...

DBTX : 4.91 (-0.81%)
Housing, Manufacturing Stats Due Next Week

Housing, Manufacturing Stats Due Next Week Monday U.S. Featured Earnings GitLab Inc. ...

GTLB : 73.03 (+1.26%)
DLO : 16.68 (+0.12%)
GOL : 2.72 (+3.23%)
LEN : 161.00 (+1.57%)
SMAR : 42.95 (+1.75%)
S : 27.81 (-1.28%)
ADBE : 572.17 (+2.12%)
FIVE : 201.42 (+0.37%)
FDX : 246.94 (-0.82%)
DG : 150.18 (+3.35%)
JBL : 147.08 (+2.08%)
JANX : 46.08 (-4.75%)
Decibel Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Update

- Announced positive data from interim analysis of Phase 1b clinical trial of DB-020 in patients receiving cisplatin chemotherapy; data support continued...

DBTX : 4.91 (-0.81%)
Decibel Therapeutics (DBTX) Receives a Buy from SVB Securities

In a report issued on June 28, Mani Foroohar from SVB Securities reiterated a Buy rating on Decibel Therapeutics (DBTX – Research Report). The company's shares closed last Wednesday at $3.82. According...

DBTX : 4.91 (-0.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Decibel Therapeutics is a clinical-stage biotechnology company. It engages in discovering and developing transformative treatments to restore and improve hearing and balance. Decibel Therapeutics is based in BOSTON.

See More

Key Turning Points

3rd Resistance Point 5.26
2nd Resistance Point 5.18
1st Resistance Point 5.05
Last Price 4.91
1st Support Level 4.84
2nd Support Level 4.76
3rd Support Level 4.63

See More

52-Week High 5.40
Last Price 4.91
Fibonacci 61.8% 3.95
Fibonacci 50% 3.51
Fibonacci 38.2% 3.06
52-Week Low 1.61

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar